Tell everyone you meet this week about the organ donor register and save lives
Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
including cancer, vaccines, a review of measures regulating the prices of medicinal products, health in the Mediterranean area, and work with health care organisations. Read more…
Now 4028 members from 106 countries
EASL Monothematic Conference: HIV and the Liver
Venue and dates
December 7-8, 2012
London, UK
Course organisers
K. Agarwal, London, UK
J.K. Rockstroh, Bonn, Germany
F. Zoulim, Lyon, France


_

EASL would like to thank everyone who attended the EASL Monothematic Conference HIV and the Liver in London, UK, at the beginning of December 2012 and also thanks the European AIDS Clinical Society (EACS) for co-sponsoring the meeting.

This was the first conference of its kind bringing together hepatologists and infectious disease specialists to address one of the critical issues in the management of HIV-infected patients: the rising mortality from liver disease.

The Conference Highlights report features the key topics discussed and presented during the EASL Monothematic Conference. This report will enable you to keep up to date with the latest happenings in the field.

 

EASL thanks the European Aids Clinical Society (EACS) Executive Committee for kindly agreeing to co-sponsor and support this EASL Monothematic Conference on HIV and hepatitis. This 2 day conference will provide an interactive forum which aims to facilitate cross-fertilisation and collaborative research efforts in the areas of HIV and hepatitis coinfection, drug toxicity and long-term complications of liver disease in HIV.

Join renowned international speakers to discuss a variety of issues including:

  • outbreaks of acute HCV in HIV
  • best management strategies for hepatitis coinfection in HIV
  • the use of DAAs as in HCV monoinfection
  • special DDIs in HIV/HCV coinfected patients
  • liver transplantation in HIV coinfection

Co-sponsored and supported by

View Infographic

 

 

This 2 day conference provides an interactive forum which aims to facilitate cross-fertilisation and collaborative research efforts in the areas of HIV and hepatitis coinfection, drug toxicity and long-term complications of liver disease in HIV.
Join a renowned international speakers to discuss a variety of issues including:
What can we learn from outbreaks of acute HCV in HIV?
What are the best management strategies for hepatitis coinfection in HIV?
Can we use DAAs just as in HCV monoinfection?
Are there any special DDIs in HIV/HCV coinfected patients that we need to consider?
How does liver transplantation work in HIV coinfection?

CME Accreditation



 

 

 

Share